🇺🇸 FDA
Patent

US 9138416

Sustained-release nanoparticle compositions and methods using the same

granted A61KA61K31/00A61K31/337

Quick answer

US patent 9138416 (Sustained-release nanoparticle compositions and methods using the same) held by Board of Regents of the University of Nebraska by and behalf of the University of Nebraska Medical Center expires Mon Sep 17 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Board of Regents of the University of Nebraska by and behalf of the University of Nebraska Medical Center
Grant date
Tue Sep 22 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 17 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
11
CPC classes
A61K, A61K31/00, A61K31/337, A61K31/436, A61K9/0019